Agios Pharmaceuticals | صافي الدخل



Net Income تغيير تاريخ
AbbVie USD 1.29B 1.31B 2025-03
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Arrowhead Research USD 370.44M 543.53M 2025-03
Astellas Pharma JPY 74.9B 172.56B 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Bayer EUR 1.3B 1.63B 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Daiichi Sankyo JPY 87.15B 25.22B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Exelixis USD 159.62M 19.76M 2025-04
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Incyte USD 158.2M 43.01M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Merck USD 5.08B 1.34B 2025-03
Moderna USD -971000000 149M 2025-03
Novartis USD 2.82B 371M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Agios Pharmaceuticals صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.